Synonym: 865479-71-6; Xarelto; BAY 59-7939; 5-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide; Factor Xa inhibitor
5-R-Rivaroxaban is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting factor Xa. The molecular weight of the compound is 435.88, and its molecular formula is C19H18ClN3O5S.
Molecular Weight
435.88
Molecular Formula
C19H18ClN3O5S
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
5-R-Rivaroxaban can be studied extensively for its potential therapeutic applications in the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke in patients with non-valvular atrial fibrillation (AF).
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
